3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Lymphoma
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Skin Carcinoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Opioid-Related Disorders
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Healthy Subject
1
Genital Neoplasms, Female
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Carboplatin
3
Cisplatin
2
veliparib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Psychiatric Nursing
1
Physical Therapy Modalities
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Etoposide
1
Educational Status
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Testicular Neoplasms
×
Educational Status
×
Clear all
NCT07228637
2026-02-09
PERSIST
Indiana University
Phase NA
Active not recruiting
70 enrolled